7Baggers
 iTeos Therapeutics highlights its immuno-oncology pipeline  Ad-hoc-news.de Tue, 07 Jul 2026 20:03:01 GMT
 MRM Health appoints Michel Detheux as Chairman of the Board  PMLiVE Thu, 25 Jun 2026 12:30:46 GMT
 iTeos Therapeutics Stock - Analyst consensus and biotech sector check  Ad-hoc-news.de Fri, 19 Jun 2026 07:00:00 GMT
 iteos therapeutics inc (itos) institutional confidence  TradingKey Thu, 18 Jun 2026 09:16:39 GMT
 tradingkey  TradingKey Thu, 14 May 2026 17:18:16 GMT
 tango therapeutics stock hits all-time high at 27.16 usd  Investing.com Tue, 21 Apr 2026 07:00:00 GMT
 tango therapeutics names matthew gall as chief financial officer by investing.com  Investing.com South Africa Wed, 15 Apr 2026 07:00:00 GMT
 iteos therapeutics stock: what investors should know now  AD HOC NEWS Tue, 07 Apr 2026 07:00:00 GMT
 itos sec filings - iteos therapeutics, inc. 10-k, 10-q, 8-k forms  Stock Titan Thu, 02 Apr 2026 07:52:47 GMT
 published on: 2026-03-20 16:48:19  baoquankhu1.vn Fri, 20 Mar 2026 09:52:00 GMT
 itos financials: income statement, balance sheet & cash flow  Stock Titan Wed, 04 Mar 2026 01:45:04 GMT
 understanding momentum shifts in (itos)  Stock Traders Daily Wed, 25 Feb 2026 16:12:01 GMT
 itos financials: income statement, balance sheet & cash flow  Stock Titan Tue, 24 Feb 2026 19:43:33 GMT
 published on: 2026-01-17 05:22:17  baoquankhu1.vn Fri, 16 Jan 2026 22:22:19 GMT
 published on: 2026-01-16 19:29:34  baoquankhu1.vn Fri, 16 Jan 2026 06:31:48 GMT
 (itos) movement within algorithmic entry frameworks  Stock Traders Daily Mon, 12 Jan 2026 11:20:01 GMT
 (itos) price dynamics and execution-aware positioning  Stock Traders Daily Sun, 21 Dec 2025 08:40:02 GMT
 published on: 2025-12-21 12:56:35  moha.gov.vn Sun, 21 Dec 2025 05:56:35 GMT
 published on: 2025-12-19 13:53:01  Улправда Fri, 19 Dec 2025 09:53:01 GMT
 published on: 2025-12-18 13:31:56  Улправда Thu, 18 Dec 2025 09:31:56 GMT
 the 5 most painful clinical trial failures of 2025  BioSpace Mon, 15 Dec 2025 08:00:00 GMT
 iteos therapeutics acquisition finalized, shares delisted  AD HOC NEWS Sun, 07 Dec 2025 08:00:00 GMT
 can iteos therapeutics inc. stock sustain free cash flow growth  newser.com Wed, 19 Nov 2025 14:52:35 GMT
 vend marketplaces asa launches nok 2 billion share buyback program  The Globe and Mail Thu, 13 Nov 2025 08:00:00 GMT

iTeos Therapeutics, Inc
(NASDAQ:ITOS) 

ITOS stock logo

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2a receptor that is an open-label Phase 1/2a...

Founded: 2012
Full Time Employees: 55
CEO: Michel Detheux  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends